The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 310.00
Bid: 307.00
Ask: 314.00
Change: 0.00 (0.00%)
Spread: 7.00 (2.28%)
Open: 315.00
High: 315.00
Low: 309.00
Prev. Close: 310.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exclusive UK Partnership

25 Jan 2007 07:02

Fisher (James) & Sons PLC25 January 2007 For release 7am Thursday 25 January 2007 James Fisher Announce Exclusive UK Partnership with Synodys Group James Fisher IMS, a subsidiary of James Fisher and Sons plc, the marine andengineering services business, announce a strategic partnership with the SynodysGroup, the global instruments and monitoring systems company. James Fisher IMS provides inspection and measurement capability to the nuclear,homeland security, defence and aerospace industries. The Synodys Health PhysicsDivision provides active dosimetry, passive dosimetry, and contamination andclearance systems as services to nuclear, military and civil defence, andmedical markets. The division is headquartered in Lamanon, France, and sellsunder the Synodys, MGP, and Rados brands. The partnership provides James Fisher IMS, which has a strong UK presence andexcellent reputation, with a comprehensive portfolio of radiation measurementsystems to satisfy its customer requirements. The UK market focus, commitmentand resources that Fisher brings to the partnership represent a major stepforward for Synodys in the UK. James Fisher IMS is now the exclusive partner for UK sales, support and service.The UK customer base is of major importance to Synodys and this partnershipsupports the goal of enhancing coverage, technical support and services to ourcustomers. Paul Read, Managing Director, James Fisher IMS, comments: "The partnership with Synodys is an important element in our strategy ofproviding the customer base with a comprehensive product and service portfolioin all markets were quality, responsiveness and value are key to our customers." Antony Besso, CEO, Synodys Health Physics, said: "James Fishers commitment to the UK customer base, coverage and complimentarycapabilities make it an ideal partner for both products and services." - ENDS - For more information contact: James Fisher IMSwww.james-fisher.co.ukPaul Read, Managing Director paul.read@jfims.co.uk 0161 232 1414 Synodys Steve Phillips sphillips@mgpi.com.fr +33 (0)490 595 959 Adventis Financial PR Peter Binns pbinns@adventis.co.uk 020 7034 4760 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Jul 20207:00 amRNSHalf year post close trading update
24th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th May 20204:41 pmRNSSecond Price Monitoring Extn
14th May 20204:36 pmRNSPrice Monitoring Extension
30th Apr 20202:51 pmRNSDisclosure of Rights Attached to Equity Shares
30th Apr 20202:49 pmRNSResult of AGM
30th Apr 20207:00 amRNSAGM trading statement & Covid-19 update
21st Apr 20209:00 amRNSHolding(s) in Company
15th Apr 20207:00 amRNSHolding(s) in Company
14th Apr 202010:20 amRNSDirector/PDMR Shareholding
1st Apr 20204:35 pmRNSPrice Monitoring Extension
31st Mar 20207:00 amRNSAnnual General Meeting and COVID-19
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:03 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSCovid-19 Update
20th Mar 20205:30 pmRNSAnnual Report and Accounts posted
20th Mar 20204:45 pmRNSDirector/PDMR Shareholding
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSDirectorate Change
18th Mar 202012:02 pmRNSPrice Monitoring Extension
18th Mar 202010:21 amRNSFinal dividend payment date
17th Mar 20203:57 pmRNSDirector/PDMR Shareholding
16th Mar 202012:07 pmRNSSecond Price Monitoring Extn
16th Mar 202012:02 pmRNSPrice Monitoring Extension
27th Feb 20204:41 pmRNSSecond Price Monitoring Extn
27th Feb 20204:36 pmRNSPrice Monitoring Extension
27th Feb 20207:00 amRNSFinal Results for the year ended 31 December 2019
21st Feb 20207:00 amRNSFour year contract extension worth £35m
13th Feb 202012:51 pmRNSDirector Shareholding Update
16th Jan 20203:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN
9th Jan 202012:07 pmRNSSecond Price Monitoring Extn
9th Jan 202012:02 pmRNSPrice Monitoring Extension
9th Jan 202011:06 amRNSDirector/PDMR Shareholding
2nd Jan 202011:19 amRNSTotal Voting Rights
6th Dec 20199:35 amRNSTotal Voting Rights and Share Capital
28th Nov 20197:00 amRNSTrading Update
5th Nov 20191:29 pmRNSNotice of cyber security incident
2nd Oct 201911:39 amRNSTotal Voting Rights and Share Capital
1st Oct 20197:00 amRNSCONFIRMATION OF APPOINTMENT OF CEO
27th Sep 20197:00 amRNSSubmarine Rescue System contract
4th Sep 20192:38 pmRNSTotal Voting Rights
28th Aug 20197:00 amRNSHalf year results
7th Aug 20197:00 amRNSAcquisition of SM Continental S.A.
16th Jul 20197:00 amRNSContract Wins
5th Jul 20197:00 amRNSAppointment of new Chief Executive Officer
1st Jul 20199:49 amRNSTotal Voting Rights
19th Jun 201911:13 amRNSBLOCK LISTING SIX MONTHLY RETURN
10th Jun 20197:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.